Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells - PubMed (original) (raw)
. 1996 Nov;279(2):617-24.
Affiliations
- PMID: 8930164
Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells
Y Watanabe et al. J Pharmacol Exp Ther. 1996 Nov.
Abstract
It is well known that amiodarone is effective for the treatment of atrial fibrillation. However, effects of amiodarone on the muscarinic acetylcholine receptor-operated K+ current (IK.ACh), which plays an important role in the repolarization of atrial action potential, have not been evaluated. This study was undertaken to determine whether amiodarone inhibits the acetyl-choline-sensitive muscarinic K+ (KACh) channel by use of the patch-clamp technique. In isolated guinea pig atrial cells, IK.ACh was activated by extracellular application of carbachol (1 microM) or adenosine (10 microM) or by the intracellular loading of GTP gamma S (100 microM). Amiodarone inhibited the IK.ACh activated in these three different ways with similar IC50 values around 2 microM, which indicated that amiodarone directly depresses the function of the KACh channel itself and/or GTP-binding proteins. Single KACh channel current was also recorded by use of a pipette solution containing carbachol (1 microM) or atropine (10 microM) plus theophylline (100 microM) in a cell-attached configuration. Amiodarone at a concentration of 3 microM significantly decreased the open probability of the KACh channel in both conditions. Amiodarone also reversed the carbachol- and adenosine-induced action potential shortening in a concentration-dependent manner. In isolated guinea pig hearts, perfusion of 1 microM carbachol shortened the effective refractory period of the atria and lowered the atrial fibrillation threshold. Addition of 10 microM amiodarone reversed these electrophysiological parameters to the control level. These results suggest that amiodarone inhibits IK.ACh by depressing the function of the KACh channel itself and/or associated GTP-binding proteins. This effect of amiodarone may at least in part be involved in the antiarrhythmic action against atrial fibrillation.
Similar articles
- Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.
Ohmoto-Sekine Y, Uemura H, Tamagawa M, Nakaya H. Ohmoto-Sekine Y, et al. Br J Pharmacol. 1999 Feb;126(3):751-61. doi: 10.1038/sj.bjp.0702334. Br J Pharmacol. 1999. PMID: 10188988 Free PMC article. - [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].
Borchard R, van Bracht M, Wickenbrock I, Prull MW, Pott L, Trappe HJ. Borchard R, et al. Med Klin (Munich). 2005 Nov 15;100(11):697-703. doi: 10.1007/s00063-005-1096-z. Med Klin (Munich). 2005. PMID: 16328176 German. - SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.
Hara Y, Nakaya H. Hara Y, et al. Br J Pharmacol. 1995 Nov;116(6):2750-6. doi: 10.1111/j.1476-5381.1995.tb17237.x. Br J Pharmacol. 1995. PMID: 8591000 Free PMC article. - Cellular electropharmacology of amiodarone.
Kodama I, Kamiya K, Toyama J. Kodama I, et al. Cardiovasc Res. 1997 Jul;35(1):13-29. doi: 10.1016/s0008-6363(97)00114-4. Cardiovasc Res. 1997. PMID: 9302343 Review.
Cited by
- Genetics and Pharmacogenetics of Atrial Fibrillation: A Mechanistic Perspective.
Owais A, Barney M, Ly OT, Brown G, Chen H, Sridhar A, Pavel A, Khetani SR, Darbar D. Owais A, et al. JACC Basic Transl Sci. 2024 Feb 28;9(7):918-934. doi: 10.1016/j.jacbts.2023.12.006. eCollection 2024 Jul. JACC Basic Transl Sci. 2024. PMID: 39170958 Free PMC article. Review. - Histamine H1-receptor-mediated modulation of the delayed rectifier K+ current in guinea-pig atrial cells: opposite effects on IKs and IKr.
Matsumoto Y, Ogura T, Uemura H, Saito T, Masuda Y, Nakaya H. Matsumoto Y, et al. Br J Pharmacol. 1999 Dec;128(7):1545-53. doi: 10.1038/sj.bjp.0702918. Br J Pharmacol. 1999. PMID: 10602335 Free PMC article. - Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels.
Staudacher I, Illg C, Chai S, Deschenes I, Seehausen S, Gramlich D, Müller ME, Wieder T, Rahm AK, Mayer C, Schweizer PA, Katus HA, Thomas D. Staudacher I, et al. Naunyn Schmiedebergs Arch Pharmacol. 2018 Oct;391(10):1119-1131. doi: 10.1007/s00210-018-1535-z. Epub 2018 Jul 14. Naunyn Schmiedebergs Arch Pharmacol. 2018. PMID: 30008082 - Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.
Nakaya H, Furusawa Y, Ogura T, Tamagawa M, Uemura H. Nakaya H, et al. Br J Pharmacol. 2000 Dec;131(7):1363-72. doi: 10.1038/sj.bjp.0703713. Br J Pharmacol. 2000. PMID: 11090108 Free PMC article. - Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations.
Sicouri S, Belardinelli L, Carlsson L, Antzelevitch C. Sicouri S, et al. J Cardiovasc Electrophysiol. 2009 Jul;20(7):803-10. doi: 10.1111/j.1540-8167.2009.01449.x. Epub 2009 Feb 27. J Cardiovasc Electrophysiol. 2009. PMID: 19298559 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources